Accessibility Menu
BioLife Solutions logo

BioLife Solutions(NASDAQ) BLFS

Current Price$30.03
Market Cap$1.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-94%
5 Year-36%
1 Year+35%
1 Month+17%
BioLife Solutions last closing stock price
MetricPriceDate
Last closeUSD 29.982026-07-24
BioLife Solutions stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.85%USD 29.152026-07-17
1 month+17.25%USD 25.572026-06-24
3 month+40.22%USD 21.382026-04-24
Year to date+23.99%USD 24.182025-12-31
1 year+34.68%USD 22.262025-07-24
3 year+54.46%USD 19.412023-07-25
5 year-35.79%USD 46.692021-07-23
Since inception-94.47%USD 542.501992-05-01

BioLife Solutions Financials at a Glance

Market Cap

$1.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$99.77M

Net Income (TTM)

-$10.50M

EPS (TTM)

-$0.28

P/E Ratio

-107.34

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Price

$30.03

Volume

119,798

Open

$30.46

Previous Close

$30.03

Daily Range

$29.93 - $30.72

52-Week Range

$17.86 - $32.23

Estimated Earnings Date

Aug 6, 2026

BLFS News

SellAlert-Blue.png

BioLife Solutions' CFO Sells 30,000 Shares

Lawrence Rothman, CFADec 11, 2025
a scientist uses a pipette to work with medical samples.

Why Shares of BioLife Solutions Plummeted This Week

James HalleyAug 11, 2023
scientists examine cell make up microscope biotech

Why Shares of BioLife Solutions Are Slumping on Wednesday

James HalleyAug 9, 2023
GettyImages-155373764

Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom

Jason HawthorneOct 15, 2021
GettyImages-1263391009

Why Shares in BioLife Solutions Jumped 24.4% in August

James HalleySep 7, 2021
Biotech scientist-microscope-getty

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday

Dan CaplingerAug 25, 2021
GettyImages-847891380

BioLife Solutions to Buy SciSafe in $30 Million Deal

Eric VolkmanSep 21, 2020
Bioproduction

Here's Why BioLife Solutions Jumped Higher Today

Brian Orelli, PhDJul 2, 2020

BLFS: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioLife Solutions

BioLife helps scientists keep living cells and tissues healthy during manufacturing. The company makes liquids and tools that prevent cell damage at freezing temperatures. These products help healthcare firms transport and prepare new genetic therapies.

The Tools of Bioproduction

  • Biopreservation Media: Liquid solutions like CryoStor that protect cells from damage during freezing; accounted for 82% of revenue in 2025.
  • Automated Thawing Devices: Water-free tools called ThawSTAR that use programmed heat to safely warm frozen biological materials.
  • Cell Processing Tools: Specialized containers and machines used to fill and store treatments while preventing contamination.
  • Cell Expansion Media: Human-based nutrients used to grow cells for research and commercial drug manufacturing.

Streamlining the Business Model

  • Acquired the remaining 90% of PanTHERA CryoSolutions Inc. in April 2025 to add new ice-control technology.
  • Completed the sale of the SAVSU shipping container business in October 2025.
  • Divested the Custom Biogenic Systems freezer business in November 2024.
  • Sold the SciSafe storage and logistics services business in November 2024.
  • Sold Global Cooling and its ultra-low temperature freezer line in April 2024.

A Focused Production Network

BioLife operates specialized clean rooms in Washington and Indiana to manufacture its sterile medical products. The company sells directly to customers and through a network of international distributors.

Tracking Financial Performance

  • Revenue was $18.8 million in Q4 2025, up 648.6% from Q4 2024.
  • Gross profit reached $12.7 million in Q4 2025, up 53.3% from the previous year.
  • Operating income was $5.8 million in Q4 2025, up 319.9% year-over-year.
  • Net income was $3.5 million in Q4 2025, down 71.6% from $12.5 million in Q4 2024.

The Bottom Line

BioLife has transitioned into a focused supplier of tools for the cell and gene therapy market. By selling off its freezer and storage units, the company now prioritizes high-margin media and processing products.

AI Generated • May 2, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

155

CEO

Roderick de Greef, MBA

Website

www.biolifesolutions.com

Headquarters

Bothell, WA 98021, US

BLFS Financials

Key Financial Metrics (TTM)

Gross Margin

63.89%

Operating Margin

-10.91%

Net Income Margin

-10.52%

Return on Equity

-2.91%

Return on Capital

-0.28%

Return on Assets

-2.62%

Earnings Yield

-0.93%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.86M

Volume

119.80K

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$63.74M

Operating Income

-$10.89M

EBITDA

-$7.46M

Operating Cash Flow

$17.90M

Capital Expenditure

-$19.69M

Free Cash Flow

-$1.79M

Cash & ST Invst.

$81.00M

Total Debt

$14.86M

BioLife Solutions Performance Analysis

BioLife Solutions annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 161,759,00035.8%
20232023-12-31USD 75,855,000-53.1%
20242024-12-31USD 74,647,000-1.6%
20252025-12-31USD 96,214,00028.9%
BioLife Solutions sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-306.2%
Q32025-09-3010.4%
Q42025-12-31-33.1%
Q12026-03-3146.4%
BioLife Solutions annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.291322.2%
20232023-12-31USD -1.56-52.7%
20242024-12-31USD -0.78-49.7%
20252025-12-31USD -0.31-60.1%
BioLife Solutions sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-3373.7%
Q32025-09-30103.8%
Q42025-12-31504.7%
Q12026-03-31-68.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$27.50M

+14.9%

Gross Profit

$17.41M

+10.3%

Gross Margin

63.31%

N/A

Market Cap

$1.46BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$9.45M

N/A

Employees

155

N/A

Net Income

$1.19M

+364.7%

EBITDA

$726.00K

+337.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$81.00M

-8.6%

Total Debt

$14.86M

-44.9%

Accounts Receivable

$13.06M

+42.4%

Inventory

$32.83M

+19.1%

Long Term Debt

$10.04M

-31.5%

Short Term Debt

$4.82M

-60.8%

Return on Assets

-2.62%

N/A

Return on Invested Capital

-2.84%

N/A

Free Cash Flow

-$658.00K

-142.4%

Operating Cash Flow

-$491.00K

-128.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HROWHarrow Health, Inc.
$38.45-8.19%
AZTAAzenta, Inc.
$27.37-3.29%
KMTSKestra Medical Technologies, Ltd.
$21.06-2.36%
STAASTAAR Surgical Company
$23.38-3.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About BLFS

What is the current price of BioLife Solutions?

BioLife Solutions is trading at $30.03 per share.

What is the 52-week range for BioLife Solutions?

Over the past 52 weeks, BioLife Solutions has traded between $17.86 and $32.23.

How much debt does BioLife Solutions have?

As of the most recent reporting period, BioLife Solutions reported total debt of $14.86M.

How much cash does BioLife Solutions have on hand?

BioLife Solutions reported $22.82M in cash and cash equivalents in its most recent financial results.

What is BioLife Solutions’s dividend yield?

BioLife Solutions does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services